Klaus Maleck
Chief Executive Officer at ITM Solucin GmbH
Profile
Klaus Maleck - Operating Partner
Klaus joined ArchiMed in 2020 as an Operating Partner.
He has over 25 years of experience in management consulting and corporate leadership in the Healthcare industry.
At ArchiMed, Klaus is particularly focused on the Biotech sector.
Klaus started his career at the Biotechnology and Genomics Center of Novartis Inc. He then joined McKinsey & Company as a Senior Consultant.
He co-founded and lead in his function as CFO BioGenerix AG, the biosimilar business of the ratiopharm group.
This was followed by Klaus assuming an executive role at Evotec AG, during which he led a major turn-around, including a Nasdaq listing and numerous corporate development activities.
Following this, he joined TETEC AG, a pioneer and market leader in cell therapy development and manufacturing, as CEO.
Klaus holds a PhD in Biochemistry from the Max-Planck Institute and an MBA.
Klaus is a German citizen and speaks fluent English.
Klaus Maleck active positions
| Companies | Position | Start |
|---|---|---|
Tissue Engineering Technologies AG
 Tissue Engineering Technologies AG BiotechnologyHealth Technology Tissue Engineering Technologies AG is a German company that manufactures bacterial and virus vaccines, toxoids and analogous products. The private company is based in Reutlingen City, Germany. The company was founded in 2000 by Hugo Hämmerle. | Corporate Officer/Principal | - |
ITM Solucin GmbH
 ITM Solucin GmbH Miscellaneous Commercial ServicesCommercial Services ITM Solucin GmbH provides scientific research and development services. The private company is based in Garching, Germany. The CEOs of the German company are Steffen Schuster, Klaus Maleck, Konstantin Zhernosekov. | Chief Executive Officer | - |
Former positions of Klaus Maleck
| Companies | Position | End |
|---|---|---|
ArchiMed SAS
 ArchiMed SAS Investment ManagersFinance ArchiMed SAS (ArchiMed) is a private equity firm founded in 2014 by Cedric Berger, David Piccoli, and Vincent Guillaumot. The firm is headquartered in Lyon, France. | Private Equity Investor | 31/03/2023 |
| European ScreeningPort GmbH | Chairman | - |
| EVOTEC SE | Director of Finance/CFO | 13/08/2010 |
Training of Klaus Maleck
| University of Strasbourg | Graduate Degree |
| Max Planck Institut für Pflanzenzüchtungsforschung | Doctorate Degree |
| Universität Educatis | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| EVOTEC SE | Health Technology |
| Private companies | 4 |
|---|---|
| European ScreeningPort GmbH | |
Tissue Engineering Technologies AG
Tissue Engineering Technologies AG BiotechnologyHealth Technology Tissue Engineering Technologies AG is a German company that manufactures bacterial and virus vaccines, toxoids and analogous products. The private company is based in Reutlingen City, Germany. The company was founded in 2000 by Hugo Hämmerle. | Health Technology |
ITM Solucin GmbH
ITM Solucin GmbH Miscellaneous Commercial ServicesCommercial Services ITM Solucin GmbH provides scientific research and development services. The private company is based in Garching, Germany. The CEOs of the German company are Steffen Schuster, Klaus Maleck, Konstantin Zhernosekov. | Commercial Services |
ArchiMed SAS
ArchiMed SAS Investment ManagersFinance ArchiMed SAS (ArchiMed) is a private equity firm founded in 2014 by Cedric Berger, David Piccoli, and Vincent Guillaumot. The firm is headquartered in Lyon, France. | Finance |
- Stock Market
- Insiders
- Klaus Maleck
